SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ICOS Corporation -- Ignore unavailable to you. Want to Upgrade?


To: Icebrg who wrote (1041)5/4/2004 1:28:37 PM
From: Icebrg  Read Replies (2) | Respond to of 1139
 
ICOS "equal weight," target price reduced

Tuesday, May 04, 2004 12:48:35 PM ET
Morgan Stanley

NEW YORK, May 4 (New Ratings) - Analysts at Morgan Stanley reiterate their "equal weight" rating on ICOS Corp (ICOS.NAS). The target price has been reduced from $40 to $36.